Rif Rahman

Radiation Oncologist | Views are my own

[Journal of Clinical Oncology @JCO_ASCO]

🎯 Inaugural Results of the Individualized Screening Trial of Innovative #Glioblastoma Therapy (INSIGhT): A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization 👉 https://t.co/6kmTmD3GU1 #BTSM @RifRahmanMD

[Dana-Farber News @DanaFarberNews]

In a study published in @JCO_ASCO, Patrick Wen, MD, @KeithLigon5 & @RifRahmanMD @DanaFarber led a first of its kind trial in #glioblastoma. The trial, called INSIGhT, has the potential to rapidly and efficiently identify therapies that benefit patients. https://t.co/MU1WPT5JMZ

[Brian Winey, PhD DABR @brianmedphys]

Wow! Chris Williams, PhD, a #medphys @BrighamRadOnc and alum of @HarvardMedPhys is heading to @NASA 🚀!

@aapmHQ
@MIT_Physics

https://t.co/cADlXK2J7R